AU2001233259A1 - Use of desloratadine for treating allergic and inflammatory conditions - Google Patents

Use of desloratadine for treating allergic and inflammatory conditions

Info

Publication number
AU2001233259A1
AU2001233259A1 AU2001233259A AU3325901A AU2001233259A1 AU 2001233259 A1 AU2001233259 A1 AU 2001233259A1 AU 2001233259 A AU2001233259 A AU 2001233259A AU 3325901 A AU3325901 A AU 3325901A AU 2001233259 A1 AU2001233259 A1 AU 2001233259A1
Authority
AU
Australia
Prior art keywords
desloratadine
inflammatory conditions
treating allergic
allergic
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233259A
Inventor
Melton B. Affrime
Christopher R. Banfield
Samir K. Gupta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26875804&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001233259(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2001233259A1 publication Critical patent/AU2001233259A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
AU2001233259A 2000-02-03 2001-02-01 Use of desloratadine for treating allergic and inflammatory conditions Abandoned AU2001233259A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17991000P 2000-02-03 2000-02-03
US60179910 2000-02-03
US09/760,588 US7405223B2 (en) 2000-02-03 2001-01-16 Treating allergic and inflammatory conditions
US09760588 2001-01-16
PCT/US2001/003453 WO2001056574A1 (en) 2000-02-03 2001-02-01 Use of desloratadine for treating allergic and inflammatory conditions

Publications (1)

Publication Number Publication Date
AU2001233259A1 true AU2001233259A1 (en) 2001-08-14

Family

ID=26875804

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233259A Abandoned AU2001233259A1 (en) 2000-02-03 2001-02-01 Use of desloratadine for treating allergic and inflammatory conditions

Country Status (8)

Country Link
US (2) US7405223B2 (en)
EP (1) EP1251852A1 (en)
JP (3) JP2003528823A (en)
AR (1) AR027937A1 (en)
AU (1) AU2001233259A1 (en)
CA (1) CA2398264C (en)
MX (1) MXPA02007557A (en)
WO (1) WO2001056574A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (en) 1999-12-20 2009-12-07 Schering Corporation Bilayer sustained release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
DE10036712A1 (en) * 2000-07-27 2002-02-28 Active Mining Ag Computer-assisted method for evaluating computer processes having characteristic features by weighting individual values using feature tree
US6599913B1 (en) * 2001-06-29 2003-07-29 Schering Corporation Treating allergic and inflammatory conditions
ES2232331T1 (en) * 2003-03-12 2005-06-01 Biogal Gyogyszergyar Rt. PROCEDURES FOR THE PREPARATION OF DESLORATADINE POLYMORPHIC FORMS.
US20140344067A1 (en) * 2013-05-15 2014-11-20 Joseph M. Connor, IV Purchase sharing systems
US10419830B2 (en) * 2014-10-09 2019-09-17 Thuuz, Inc. Generating a customized highlight sequence depicting an event
US10433030B2 (en) * 2014-10-09 2019-10-01 Thuuz, Inc. Generating a customized highlight sequence depicting multiple events
US10536758B2 (en) * 2014-10-09 2020-01-14 Thuuz, Inc. Customized generation of highlight show with narrative component
CN104645899B (en) * 2015-02-11 2016-08-24 郑州大学 Quickly prepare the impact flow reactor of gas hydrates and corollary system and method
US20180187263A1 (en) 2017-01-05 2018-07-05 Iowa State University Research Foundation, Inc. Kits for diagnostic detection and prevention of feedlot bovine respiratory disease

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3940485A (en) 1973-12-12 1976-02-24 Levinson Harold N Treatment and pre-treatment of dysmetric dyslexia by improving sequential scanning and ocular fixation abilities and therapeutic compounds
US4008796A (en) 1974-03-26 1977-02-22 General Concrete Of Canada Limited Control method for feeding items on a conveyor
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4282233B1 (en) 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
HU194864B (en) 1984-02-15 1988-03-28 Schering Corp Process for production of 8-chlor-6,11-dihydro-11-(4-piperidilidene)-5h-benzo (5,6)-cyclo-hepta (1,2-b) pyridine and its salts
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4731447A (en) 1985-05-13 1988-03-15 Schering Corporation Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof
US4804666A (en) 1985-08-14 1989-02-14 Schering Corporation Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines
JPS6396126A (en) 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd Stabilized composition
US5089496A (en) 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4777170A (en) 1987-02-03 1988-10-11 Heinrich William A Method to prevent and treat the signs and symptoms of motion sickness
US4863931A (en) 1988-09-15 1989-09-05 Schering Corporation Antihistaminic fluoro substituted benzocycloheptapyridines
US5019591A (en) 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
US4990535A (en) 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
ZA914764B (en) 1990-06-22 1992-03-25 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene,piperidylidene and piperazine compounds,compositions and methods of use
JPH06504772A (en) 1990-12-18 1994-06-02 ザ　ウエルカム　ファウンデーション　リミテッド Drugs that enhance the efficacy of anticancer drugs and exhibit anti-multidrug resistance
PT100502A (en) 1991-05-20 1993-08-31 Alza Corp PHARMACEUTICAL COMPOSITIONS FOR INCREASING THE CAPACITY OF PERMEACAO IN THE SKIN USING GLYCEROL MONOLINOLEATE
ES2042421B1 (en) 1992-05-22 1994-08-01 Uriach & Cia Sa J PROCEDURE FOR OBTAINING 8-CHLORINE-11- * 1 - * (5-METHYL-3-PIRIDIL) METHYL * -4-PIPERIDILIDEN * -6,11-DIHYDRO-5H-BENZO * 5,6 * CYCLOHEPTA * 1 , 2-B * PIRIDINE.
ATE170749T1 (en) * 1992-09-24 1998-09-15 Sepracor Inc USE OF (-)CETIRIZINE FOR THE TREATMENT OF ALLERGIC RHINITIS AND AND ASTHMA
US5314697A (en) 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5502080A (en) * 1994-11-01 1996-03-26 Hitzig; Pietr Combined use of dopamine and serotonin agonists in the treatment of allergic disorders
DE4442999A1 (en) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmaceutical composition containing an active loratidine metabolite
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US5839430A (en) * 1996-04-26 1998-11-24 Cama; Joseph Combination inhaler and peak flow rate meter
TW522014B (en) 1997-02-07 2003-03-01 Sepracor Inc Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
US5900421A (en) 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5939426A (en) 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US6506767B1 (en) 1997-07-02 2003-01-14 Schering Corporation 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
UA62976C2 (en) 1997-07-02 2004-01-15 Schering Corp Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
US6270796B1 (en) 1997-10-29 2001-08-07 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
DK1041990T3 (en) 1997-12-23 2006-10-02 Schering Corp Composition for the treatment of respiratory and skin diseases with at least one leukotriene antagonist and at least one antihistamine
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
DE69916042T2 (en) 1998-07-10 2004-11-11 Schering Corp. ORAL COMPOSITIONS WITH 8-CHLORO-6,11-DIHYDRO-11- (4-PIPERIDYLIDEN) -5H-BENZO [5,6] CYCLOHEPTA [1,2-B] PYRIDINE
US6423721B1 (en) 1998-09-10 2002-07-23 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US6051585A (en) 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6100274A (en) 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
EP1214072A2 (en) 1999-09-21 2002-06-19 Schering Corporation Use of desloratadine for treating allergic and inflammatory conditions
AU7589700A (en) 1999-09-22 2001-04-24 Schering Corporation Treating allergic and inflammatory conditions
US6114346A (en) 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
SK287105B6 (en) 1999-12-20 2009-12-07 Schering Corporation Bilayer sustained release oral dosage composition
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
MXPA02006347A (en) 1999-12-21 2002-12-13 Schering Aktiengesllschft Treating allergic and inflammatory conditions.
HUP0204048A3 (en) * 2000-02-03 2004-07-28 Schering Corp Use of desloratadine for treating allergic and inflammatory conditions
US7405223B2 (en) * 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US6599913B1 (en) 2001-06-29 2003-07-29 Schering Corporation Treating allergic and inflammatory conditions
US20030004179A1 (en) 2002-05-21 2003-01-02 Affrime Melton B Treating allergic and inflammatory conditions

Also Published As

Publication number Publication date
JP2012131828A (en) 2012-07-12
CA2398264C (en) 2012-08-21
AR027937A1 (en) 2003-04-16
MXPA02007557A (en) 2002-12-13
US7902208B2 (en) 2011-03-08
EP1251852A1 (en) 2002-10-30
CA2398264A1 (en) 2001-08-09
WO2001056574A1 (en) 2001-08-09
JP2003528823A (en) 2003-09-30
US7405223B2 (en) 2008-07-29
US20020019409A1 (en) 2002-02-14
JP2008110989A (en) 2008-05-15
US20080262018A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
AU2001249918A1 (en) Inhibitors of inflammation and reperfusion injury and methods of use thereof
AU2001275257A1 (en) Methods and devices for the treatment of urinary incontinence
AU2002352726A1 (en) Formulations and methods for treatment or amelioration of inflammatory conditions
AU2002314466A1 (en) Withasol and methods of use
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
HK1049115A1 (en) Compositions and methods for treatment of allergic disorders
AU6739001A (en) Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
AU2001233259A1 (en) Use of desloratadine for treating allergic and inflammatory conditions
HUP0204048A3 (en) Use of desloratadine for treating allergic and inflammatory conditions
AU2001274181A1 (en) Composition and method for biocide treatment of surfaces
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
AU2002366028A1 (en) Use of fk506 and analogues for treating allergic diseases
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU2002228660A1 (en) Use of amidoamines to treat or prevent acanthamoeba and fungal infections
AU2001268236A1 (en) Use of aicar and related compounds
AU2001292818A1 (en) Use of transcription factors for treating inflammation and other diseases
AU6746501A (en) Methods for prevention of ulcers and improving physiological performance
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2002306845A1 (en) Telomerase inhibitors and methods of their use
AU7704200A (en) Treating allergic and inflammatory conditions
AU2277301A (en) Treating allergic and inflammatory conditions